379 related articles for article (PubMed ID: 27703373)
1. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
[TBL] [Abstract][Full Text] [Related]
2. Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer.
Wu Q; Wang J; Liu Y; Gong X
Int J Clin Exp Pathol; 2019; 12(5):1678-1689. PubMed ID: 31933986
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
[TBL] [Abstract][Full Text] [Related]
4. T-cadherin is associated with prognosis in triple-negative breast cancer.
Kong DD; Wang MH; Yang J; Li L; Wang W; Wang SB; Zhou YZ
Oncol Lett; 2017 Sep; 14(3):2975-2981. PubMed ID: 28928835
[TBL] [Abstract][Full Text] [Related]
5. Subcellular expression of MTA1, HIF1A and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study.
Sharaf SS; Jaganath Krishna KM; Lekshmi A; Sujathan
J Mol Histol; 2024 Jun; 55(3):303-315. PubMed ID: 38613589
[TBL] [Abstract][Full Text] [Related]
6. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
[TBL] [Abstract][Full Text] [Related]
7. Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer.
Zou W; Yang Y; Zheng R; Wang Z; Zeng H; Chen Z; Yang F; Wang J
Int J Clin Exp Pathol; 2020; 13(5):1008-1016. PubMed ID: 32509072
[TBL] [Abstract][Full Text] [Related]
8. Significance of E-cadherin expression in triple-negative breast cancer.
Kashiwagi S; Yashiro M; Takashima T; Nomura S; Noda S; Kawajiri H; Ishikawa T; Wakasa K; Hirakawa K
Br J Cancer; 2010 Jul; 103(2):249-55. PubMed ID: 20551954
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide.
Sun W; Li C; Liu M; Liu W; Yang C; Cai LI
Oncol Lett; 2016 Mar; 11(3):2320-2326. PubMed ID: 26998170
[TBL] [Abstract][Full Text] [Related]
10. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
Kong C; Wang C; Wang L; Ma M; Niu C; Sun X; Du J; Dong Z; Zhu S; Lu J; Huang B
PLoS One; 2011; 6(7):e22666. PubMed ID: 21829474
[TBL] [Abstract][Full Text] [Related]
11. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
[TBL] [Abstract][Full Text] [Related]
12. Combined high NEDD9 expression and E-cadherin loss correlate with poor clinical outcome in gastric cancer.
Im S; Cho YK; Kang D; Shin GY; Jung ES; Song KY; Lee SH; Park JM
J Gastroenterol Hepatol; 2022 Dec; 37(12):2255-2263. PubMed ID: 36203318
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients.
Zhang WJ; Wang XH; Gao ST; Chen C; Xu XY; Sun Q; Zhou ZH; Wu GZ; Yu Q; Xu G; Yao YZ; Guan WX
J Surg Res; 2018 Feb; 222():93-101. PubMed ID: 29273380
[TBL] [Abstract][Full Text] [Related]
14. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
Jing N; Ma MW; Gao XS; Liu JT; Gu XB; Zhang M; Zhao B; Wang Y; Wang XL; Jia HX
Ann Transl Med; 2020 Nov; 8(21):1447. PubMed ID: 33313192
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.
Qiu J; Xue X; Hu C; Xu H; Kou D; Li R; Li M
J Cancer; 2016; 7(2):167-73. PubMed ID: 26819640
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer.
Zhang YQ; Zhang F; Zeng YZ; Chen M; Huang WH; Wu JD; Chen WL; Gao WL; Bai JW; Yang RQ; Zeng HC; Wei XL; Zhang GJ
Front Oncol; 2021; 11():628814. PubMed ID: 34249678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]